- Home
- SXTC vs WHF Comparison
SXTC vs WHF Comparison
Compare SXTC & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SXTC | WHF |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.7M | 162.5M |
| IPO Year | 2019 | 2012 |
Fundamental Metrics
Financial Performance| Metric | SXTC | WHF |
|---|---|---|
| Price | $2.52 | $6.71 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.75 |
| AVG Volume (30 Days) | ★ 697.1K | 107.7K |
| Earning Date | 08-19-2019 | 03-06-2026 |
| Dividend Yield | N/A | ★ 15.85% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | $1,537,987.00 | ★ $76,339,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.39 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.34 | $6.39 |
| 52 Week High | $1,175.99 | $11.31 |
Technical Indicators
Market Signals| Indicator | SXTC | WHF |
|---|---|---|
| Relative Strength Index (RSI) | 59.84 | 46.98 |
| Support Level | $2.34 | $6.41 |
| Resistance Level | $6.40 | $6.83 |
| Average True Range (ATR) | 0.42 | 0.15 |
| MACD | 0.24 | -0.00 |
| Stochastic Oscillator | 39.18 | 51.83 |
Price Performance
Historical ComparisonAbout SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.